Dr. Anthony Pak-Yin Liu, MBBS, MMedSc, received his medical degree from the University of Hong Kong in 2009. He completed a residency in pediatrics and training in pediatric hematology/oncology at Queen Mary Hospital, Hong Kong, as well as a Master’s degree in genetic counseling. A keen clinician-scientist with an interest in pediatric central nervous system tumors, Dr Liu further trained as a Pediatric Neuro-Oncology Fellow at St. Jude Children’s Research Hospital, Memphis, TN, between 2017 and 2020 under the mentorship of Drs. Amar Gajjar and Paul Northcott. Dr. Anthony Liu joined the staff at The Hospital for Sick Children (SickKids) in 2024. His ongoing research is focused on biomarker development, circulating tumor material, and the molecular characterization of pediatric brain tumors, including medulloblastoma, pineoblastoma, and other embryonal tumors.
Dr. Anthony Pak-Yin Liu, MBBS, MMedSc, received his medical degree from the University of Hong Kong in 2009. He completed a residency in pediatrics and training in pediatric hematology/oncology at Queen Mary Hospital, Hong Kong, as well as a Master’s degree in genetic counseling. A keen clinician-scientist with an interest in pediatric central nervous system tumors, Dr Liu further trained as a Pediatric Neuro-Oncology Fellow at St. Jude Children’s Research Hospital, Memphis, TN, between 2017 and 2020 under the mentorship of Drs. Amar Gajjar and Paul Northcott. Dr. Anthony Liu joined the staff at The Hospital for Sick Children (SickKids) in 2024. His ongoing research is focused on biomarker development, circulating tumor material, and the molecular characterization of pediatric brain tumors, including medulloblastoma, pineoblastoma, and other embryonal tumors.